Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Scott A Handley

Showing results (71-80 of 80) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 80 results.
Med (New York, N.Y.)|November 23, 2021
Reduced antibody activity against SARS-CoV-2 B.1.617.2 delta virus in serum of mRNA-vaccinated individuals receiving tumor necrosis factor-α inhibitorsRita E Chen, Matthew J Gorman, Daniel Y Zhu, et al.
Biorxiv : the Preprint Server for Biology|March 22, 2023
Host interactions of novel <i>Crassvirales</i> species belonging to multiple families infecting bacterial host, <i>Bacteroides cellulosilyticus</i> WH2Bhavya Papudeshi, Alejandro A Vega, Cole Souza, et al.
Microbial Genomics|September 4, 2023
Host interactions of novel <i>Crassvirales</i> species belonging to multiple families infecting bacterial host, <i>Bacteroides cellulosilyticus</i> WH2Bhavya Papudeshi, Alejandro A Vega, Cole Souza, et al.
Nature Communications|July 2, 2022
Resilience of S309 and AZD7442 monoclonal antibody treatments against infection by SARS-CoV-2 Omicron lineage strainsJames Brett Case, Samantha Mackin, John M Errico, et al.
Science (New York, N.Y.)|April 14, 2018
Tropism for tuft cells determines immune promotion of norovirus pathogenesisCraig B Wilen, Sanghyun Lee, Leon L Hsieh, et al.
Immunity|September 5, 2021
A potently neutralizing SARS-CoV-2 antibody inhibits variants of concern by utilizing unique binding residues in a highly conserved epitopeLaura A VanBlargan, Lucas J Adams, Zhuoming Liu, et al.
Cell Metabolism|December 5, 2020
Intercellular Mitochondria Transfer to Macrophages Regulates White Adipose Tissue Homeostasis and Is Impaired in ObesityJonathan R Brestoff, Craig B Wilen, John R Moley, et al.
Science (New York, N.Y.)|July 4, 2015
Protective efficacy of adenovirus/protein vaccines against SIV challenges in rhesus monkeysDan H Barouch, Galit Alter, Thomas Broge, et al.
The Journal of Biological Chemistry|March 3, 2018
LysMD3 is a type II membrane protein without an <b></b> role in the response to a range of pathogensChristine C Yokoyama, Megan T Baldridge, Daisy W Leung, et al.
Nature|June 21, 2021
In vivo monoclonal antibody efficacy against SARS-CoV-2 variant strainsRita E Chen, Emma S Winkler, James Brett Case, et al.
Pageof 8

Showing results (71-80 of 80) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 80 results.
Med (New York, N.Y.)|November 23, 2021
Reduced antibody activity against SARS-CoV-2 B.1.617.2 delta virus in serum of mRNA-vaccinated individuals receiving tumor necrosis factor-α inhibitorsRita E Chen, Matthew J Gorman, Daniel Y Zhu, et al.
Biorxiv : the Preprint Server for Biology|March 22, 2023
Host interactions of novel <i>Crassvirales</i> species belonging to multiple families infecting bacterial host, <i>Bacteroides cellulosilyticus</i> WH2Bhavya Papudeshi, Alejandro A Vega, Cole Souza, et al.
Microbial Genomics|September 4, 2023
Host interactions of novel <i>Crassvirales</i> species belonging to multiple families infecting bacterial host, <i>Bacteroides cellulosilyticus</i> WH2Bhavya Papudeshi, Alejandro A Vega, Cole Souza, et al.
Nature Communications|July 2, 2022
Resilience of S309 and AZD7442 monoclonal antibody treatments against infection by SARS-CoV-2 Omicron lineage strainsJames Brett Case, Samantha Mackin, John M Errico, et al.
Science (New York, N.Y.)|April 14, 2018
Tropism for tuft cells determines immune promotion of norovirus pathogenesisCraig B Wilen, Sanghyun Lee, Leon L Hsieh, et al.
Immunity|September 5, 2021
A potently neutralizing SARS-CoV-2 antibody inhibits variants of concern by utilizing unique binding residues in a highly conserved epitopeLaura A VanBlargan, Lucas J Adams, Zhuoming Liu, et al.
Cell Metabolism|December 5, 2020
Intercellular Mitochondria Transfer to Macrophages Regulates White Adipose Tissue Homeostasis and Is Impaired in ObesityJonathan R Brestoff, Craig B Wilen, John R Moley, et al.
Science (New York, N.Y.)|July 4, 2015
Protective efficacy of adenovirus/protein vaccines against SIV challenges in rhesus monkeysDan H Barouch, Galit Alter, Thomas Broge, et al.
The Journal of Biological Chemistry|March 3, 2018
LysMD3 is a type II membrane protein without an <b></b> role in the response to a range of pathogensChristine C Yokoyama, Megan T Baldridge, Daisy W Leung, et al.
Nature|June 21, 2021
In vivo monoclonal antibody efficacy against SARS-CoV-2 variant strainsRita E Chen, Emma S Winkler, James Brett Case, et al.
Pageof 8